ProTrials Research Expands Clinical Suite
Preeminent clinical research organization to exhibit at upcoming Outsourcing in Clinical Trials meeting in Burlingame, CA
San Jose, CA - ProTrials Research, Inc., a leader in the clinical research organization (CRO) industry, announced today the expansion of their suite of services to include data management. In response to the evolving needs of their clients, ProTrials has broadened their offering, adding both data management services and a variety of electronic data capture (EDC) platforms, which allow for a customized approach to meet individual client needs.
"At ProTrials, we are committed to advancing the quality of clinical trials," said Jodi Andrews, Co-Founder and Co-CEO of ProTrials. "We are pleased to work toward a full service offering by providing our clients with data management and EDC services, both of which support our efforts toward providing full service capabilities to our clients."
Launched in 1996 by industry veterans Jodi Andrews and Inger Arum, ProTrials is a multi-million dollar global organization dedicated to improving the quality of clinical research. With a 90 percent repeat customer base, ProTrials maintains a reputation for excellence as a quality-focused CRO. Over the last two decades, their growth and ability to successfully manage clinical trials of any size and scale have earned them attention from national and local media sources such as Inc. magazine and the Silicon Valley Business Journal, to accolades from industry experts at CenterWatch.
"Our global team of clinical research professionals has sustained a reputation for consistently delivering high-quality results," said Inger Arum, Co-Founder and Co-CEO of ProTrials. "By diversifying and expanding our services, we aim to continue to exceed our clients' expectations, while also delivering on our pledge to approach and manage each clinical trial with considerable care, professionalism and expertise."
ProTrials will be exhibiting at the Outsourcing in Clinical Trials, West Coast (OCT) conference in Burlingame, CA, February 22-23, 2017. Members of the leadership team will be available to discuss the company's capabilities across the clinical trials spectrum, as well as their expertise in multiple therapeutic areas including oncology, ophthalmology, and infectious disease. To learn more about the conference, please visit www.arena-international.com/octwestcoast.
Please visit www.protrials.com to learn more about the suite of clinical research services offered by ProTrials, and join the conversation on Facebook or LinkedIn.
About ProTrials Research, Inc.
Founded in 1996, ProTrials Research, Inc. is a clinical research organization (CRO) headquartered in San Jose, CA, with clinical operations personnel located throughout North America and worldwide. The company works with clients in the pharmaceutical, biotechnology and medical device industries, providing high quality study management, site monitoring, project management and associated clinical operations services. ProTrials Global Limited, the company's UK-based subsidiary, supports European-based clinical activities. ProTrials also has international partners that offer local support in countries throughout Asia, Latin America and Australia. For more information or to discuss your clinical research needs, please visit www.protrials.com or call 650.864.9195.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
